Raphaël MetropDirector, Transaction Advisory

    Raphaël Metrop

    Director, Transaction Advisory

    Raphaël Metrop, PharmD, has international experience in corporate and business development, mainly acquired in a start-up environment in direct contact with CEOs and Board Members.

    As the Corporate Business Development Manager of Imaxio, now known as Osivax, he had the chance to work on a wide range of projects in the field of immunology, including acquisition and divestment operations, in and out-licensing deals, submission of grant applications, creation of public-private consortiums, management of R&D programs and monitoring of patent portfolios. Before joining Alira Health in October 2018, Raphaël was Head of Corporate Business Development of Fab’entech, and had simultaneously founded a small consulting company providing services to a French family office.

    Raphaël graduated from the University of Lyon, France, with a Pharmaceutical Doctorate, and from the IMIS Institute, France, with a Masters Degree in marketing and management. He has also been granted in 2016 with an International Certificate in Corporate Finance from HEC Paris, France.